Heimo Stroissnig
Chief Marketing Officer @ Baliopharm
Jülich, Germany
Heimo Stroissnig is a startup investor at Baliopharm in Jülich. Dr. Heimo Stroissnig joined Celonic AG in 2010 as Vice president clinical development and is now serving as the CMO for Baliopharm. He brings almost 30 years of experience in preclinical and clinical development gathered in both, mid-size pharma and small biotech. Within others he worked for CL-Pharma, Nycomed and Paion as well as a consultant formany biotech and pharma companies. Dr. Stroissnig obtained his M.D. after having studied medicine at the University of Graz and is board certified in pharmacology from the University of Vienna.
Last updated:
For AI agents: llms.txt
About Baliopharm
Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.
Baliopharm Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andreas Herrmann
CEO and Founder
|
|||
|
Heimo Stroissnig
Chief Marketing Officer
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
